Collaboration to improve process analytical technologies and AAV manufacturing for gene therapies
August 23, 2023
Rentschler Biopharma, Cell and Gene Therapy Catapult and Refeyn announce collaboration The collaborators will use automated and digital technologies to improve the process of manufacturing adeno-associated viruses (AAV) Stevenage and London, UK, and Laupheim, Germany– Rentschler Biopharma, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), announces a [...]
August 23, 2023
KineMatik provides automated Business Process and Project Management Solutions integrated with OpenText's Content Cloud business Waterloo, ON – OpenText™ (NASDAQ: OTEX), (TSX: OTEX) today announced the addition of automated Business Process and Project Management Solutions to the OpenText Content business through the acquisition of KineMatik. Based in Cork, Ireland, KineMatik provides workflow automation, Document Change Control, Project Management [...]
Xcell Biosciences and Labcorp Achieve Key Data Milestones in Cell and Gene Therapy Collaboration
August 23, 2023
Results generated to date serve as basis for new IP filings and conference presentations, and have led to an expansion of the collaboration beyond CAR T cells SAN FRANCISCO -- Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has achieved key milestones in its R&D collaboration [...]
Curi Bio Awarded Over $4.4M in NIH Grants to Advance Translational Science
August 23, 2023
SEATTLE -- Curi Bio, the industry leader in developing human stem cell-based platforms for drug discovery, proudly announces two recent SBIR grants worth $4.4 million from the National Institutes of Health (NIH) to support its pioneering work on implementing human models to advance discovery of the next generation of medicines. The first project will support [...]
August 22, 2023
Applied Biosystems™ CytoScan™ HD Accel array delivers the fastest chromosomal microarray analysis workflow in the industry and improved coverage CARLSBAD, Calif. -- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency and profitability with an industry-leading two-day turnaround [...]
Unchained Labs adds big-time horsepower with new CCO!
August 22, 2023
Pleasanton, CA – Unchained Labs, the life science tools company that’s all about getting biologics and gene therapy researchers the right tools for the job, announced today that life sciences ace, Scott Thomas, has joined the Company as Chief Commercial Officer. Scott has some serious street cred when it comes to scaling life science commercial [...]
Veeva Vault LIMS to Support Civica Rx Quality Control
August 22, 2023
Nonprofit generic drug manufacturer building foundation for end-to-end quality management PLEASANTON, CA — Veeva Systems (NYSE: VEEV) today announced that Civica Rx (Civica) has adopted Veeva Vault LIMS to optimize quality control. Vault LIMS builds on Civica’s success with Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training and establishes a foundation for unified lab and quality processes to support a [...]
STARLIMS ACQUIRES LABSTEP, EXPANDING ITS PORTFOLIO ACROSS R&D THROUGH PRODUCT COMMERCIALIZATION
August 22, 2023
Labstep’s Electronic Laboratory Notebook will deliver deeper R&D capabilities to support customers in ideation phase of product development Hollywood, FL / London, UK – Today STARLIMS, a leading provider of enterprise informatics solutions, announces the expansion of its solution suite through the strategic acquisition of Labstep, a cutting-edge, R&D Electronic Laboratory Notebook (ELN). This acquisition [...]
SOPHiA GENETICS Expands Relationship with Gustave Roussy
August 22, 2023
Gustave Roussy uses SOPHiA DDM™ Platform to empower confident, data-driven medicine in the fight against cancer BOSTON and ROLLE, Switzerland -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced the expansion of its relationship with Gustave Roussy, the leading cancer center in Europe. With the expanded relationship SOPHiA GENETICS will now further [...]
August 22, 2023
SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today released its environmental, social and governance (ESG) report for 2023, highlighting Twist’s approach to sustainability, social responsibility and commitment to ethics. “We took a big step forward in our [...]

